Medicinálny Kyslík Plynný Siad (Oxygen)

Oxygen delivered by this gas raises the partial pressure of inhaled oxygen, promoting diffusion across the alveolar membrane into the bloodstream. The increased arterial oxygen tension allows hemoglobin to become fully saturated, delivering more oxygen to tissues and supporting aerobic cellular metabolism, which is essential for organ function and recovery.

The dose of medical oxygen is individualized. A prescriber determines the appropriate flow rate, concentration and duration based on the patient’s oxygen saturation, underlying condition and clinical response. Dosage is adjusted to achieve target oxygen levels while avoiding excess exposure.

Safety data for supplemental oxygen in pregnancy and lactation are limited, but short‑term use under medical supervision is generally considered acceptable when clinically indicated. The prescriber should weigh potential benefits against any theoretical risks and monitor both mother and fetus closely.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medicinálny Kyslík Plynný Siad is a compressed gas supplied in cylinders for nasal delivery, offering precise flow control and portability. Compared with liquid oxygen systems, it requires less specialized storage infrastructure but may have lower volume capacity. It provides a reliable alternative to bedside oxygen concentrators when high‑purity gas is needed.

Store the cylinders at ambient temperature below 25 °C, upright in a well‑ventilated area away from heat sources and direct sunlight. Keep the cylinders secured to prevent tipping, protect the valve from damage, and ensure that all personnel are trained in safe handling of compressed gases.

The gas is administered through a nasal cannula or mask, allowing the patient to inhale supplemental oxygen directly. The prescriber sets the flow rate on the regulator, and the device delivers a controlled concentration of oxygen to maintain the desired blood oxygen saturation.

Serious risks include hyperoxia, which can cause lung injury or pulmonary edema, and the heightened fire hazard when oxygen is present near open flames or smoking materials. In rare cases, prolonged high‑concentration exposure may lead to seizures or, in neonates, retinopathy of prematurity.

Patients with untreated pneumothorax, severe chronic obstructive pulmonary disease who are at risk of CO₂ retention, or those with known hypersensitivity to oxygen delivery devices should not receive this product without careful medical evaluation. Additionally, individuals in environments where fire risk cannot be controlled should avoid its use.